Royalty Pharma plc 8-K

What Happened

• Royalty Pharma plc announced its financial results for the quarter and year ended December 31, 2025 in a press release dated February 11, 2026. The company furnished that press release as Exhibit 99.1 to its Form 8-K (filed Feb 11, 2026).

Key Details

• Event reported under Item 2.02 (Results of Operations and Financial Condition).
• Press release dated February 11, 2026 was attached as Exhibit 99.1 to the Form 8-K.
• The disclosure covers both the quarter and the full year ended December 31, 2025.
• The filing also includes the Inline XBRL cover page (Exhibit 104).

Why It Matters

• This filing is the company’s official public release of its recent quarterly and annual financial results (earnings, revenue and other performance metrics will be in the press release).
• Investors should read the attached press release (Exhibit 99.1) for the specific results, trends, and any commentary that could affect Royalty Pharma’s stock, valuation, or outlook.